Search research articles
Contact Us
Filters
Showing results (21-30 of 144) with videos related to
Page
of 15
Sort By:
Advances in Hematology
|
May 29, 2010
beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
Luca Melchiori, Sara Gardenghi, Stefano Rivella
Haematologica
|
June 22, 2023
Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis
Amaliris Guerra, Hamideh Parhiz, Stefano Rivella
Blood
|
March 11, 2018
Hepcidin agonists as therapeutic tools
Carla Casu, Elizabeta Nemeth, Stefano Rivella
Annals of the New York Academy of Sciences
|
February 27, 2016
New strategies to target iron metabolism for the treatment of beta thalassemia
Paraskevi Rea Oikonomidou, Carla Casu, Stefano Rivella
Nature Reviews. Drug Discovery
|
February 4, 2017
Targeting iron metabolism in drug discovery and delivery
Bart J Crielaard, Twan Lammers, Stefano Rivella
Expert Review of Hematology
|
June 15, 2011
Prospects for a hepcidin mimic to treat β-thalassemia and hemochromatosis
Nermi L Parrow, Sara Gardenghi, Stefano Rivella
Advances in Hematology
|
September 24, 2010
Crosstalk between Erythropoiesis and Iron Metabolism
Stefano Rivella, Elizabeta Nemeth, Jeffery Lynn Miller
Hematology/Oncology Clinics of North America
|
November 16, 2010
Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia
Sara Gardenghi, Robert W Grady, Stefano Rivella
Blood
|
March 6, 2002
Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene
Chad May, Stefano Rivella, Amy Chadburn, et al.
American Journal of Hematology
|
November 21, 2020
Management of non-transfusion-dependent β-thalassemia (NTDT): The next 5 years
Khaled M Musallam, Stefano Rivella, Ali T Taher
Page
of 15
Search research articles
Search
Showing results (21-30 of 144) with videos related to
Sort By:
Page
of 15
Advances in Hematology
|
May 29, 2010
beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
Luca Melchiori, Sara Gardenghi, Stefano Rivella
Haematologica
|
June 22, 2023
Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis
Amaliris Guerra, Hamideh Parhiz, Stefano Rivella
Blood
|
March 11, 2018
Hepcidin agonists as therapeutic tools
Carla Casu, Elizabeta Nemeth, Stefano Rivella
Annals of the New York Academy of Sciences
|
February 27, 2016
New strategies to target iron metabolism for the treatment of beta thalassemia
Paraskevi Rea Oikonomidou, Carla Casu, Stefano Rivella
Nature Reviews. Drug Discovery
|
February 4, 2017
Targeting iron metabolism in drug discovery and delivery
Bart J Crielaard, Twan Lammers, Stefano Rivella
Expert Review of Hematology
|
June 15, 2011
Prospects for a hepcidin mimic to treat β-thalassemia and hemochromatosis
Nermi L Parrow, Sara Gardenghi, Stefano Rivella
Advances in Hematology
|
September 24, 2010
Crosstalk between Erythropoiesis and Iron Metabolism
Stefano Rivella, Elizabeta Nemeth, Jeffery Lynn Miller
Hematology/Oncology Clinics of North America
|
November 16, 2010
Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia
Sara Gardenghi, Robert W Grady, Stefano Rivella
Blood
|
March 6, 2002
Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene
Chad May, Stefano Rivella, Amy Chadburn, et al.
American Journal of Hematology
|
November 21, 2020
Management of non-transfusion-dependent β-thalassemia (NTDT): The next 5 years
Khaled M Musallam, Stefano Rivella, Ali T Taher
Page
of 15